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Background: By the year 2020 depression would be the second major cause of disability adjusted life years lost, as
reported by the World Health Organization. Depression is a mental illness which causes persistent low mood, a
sense of despair, and has multiple risk factors. Its prevalence in primary care varies between 15.3-22%, with global
prevalence up to 13% and between 17-46% in Saudi Arabia. Despite several studies that have shown benefit of
early diagnosis and cost-savings of up to 80%, physicians in primary care setting continue to miss out on 30-50%
of depressed patients in their practices.
Methods: A cross sectional study was conducted at three large primary care centers in Riyadh, Saudi Arabia aiming
at estimating point prevalence of depression and screening cost among primary care adult patients, and
comparing Patient Health Questionnaires PHQ-2 with PHQ-9. Adult individuals were screened using Arabic version
of PHQ-2 and PHQ-9. PHQ-2 scores were correlated with PHQ-9 scores using linear regression. A limited cost-
analysis and cost saving estimates of depression screening was done using the Human Capital approach.
Results: Patients included in the survey analysis were 477, of whom 66.2% were females, 77.4% were married, and
nearly 20% were illiterate. Patients exhibiting depressive symptoms on the basis of PHQ9 were 49.9%, of which 31%
were mild, 13.4% moderate, 4.4% moderate-severe and 1.0% severe cases. Depression scores were significantly
associated with female gender (p-value 0.049), and higher educational level (p-value 0.002). Regression analysis
showed that PHQ-2 & PHQ-9 were strongly correlated R = 0.79, and R2 = 0.62. The cost-analysis showed savings of
up to 500 SAR ($133) per adult patient screened once a year.
Conclusion: The point prevalence of screened depression is high in primary care visitors in Saudi Arabia. Gender
and higher level of education were found to be significantly associated with screened depression. Majority of cases
were mild to moderate, PHQ-2 was equivocal to PHQ 9 in utility and that screening for depression in primary care
setting is cost saving.
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Depression is a mental illness that causes persistent low
mood and a sense of despair in the suffering person [1]. It
makes a person feel sad, frustrated, hopeless, have low
self-esteem, and lose interest in things one usually enjoys
[2]. Between 45-95% (overall 69%) of patients with depres-
sion present with somatic symptoms [3]. Depression has
multiple underlying risk factors such as chronic medical
illness, stress, chronic pain, family history, female gender,
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The prevalence of depression in primary care setting
varies according to the subtype, with major depression at
4.8-8.6%, dysthymia between 2.1-3.7%, and minor depres-
sion around 8.4-9.7%. Cumulative prevalence for all types
of depression is between 15.3-22%, for patients seen in pri-
mary care [5,6]. According to 2001 Health Report of
WHO, nearly 15% of patients with major depression have
lifetime risk of committing suicide [7], although recent es-
timates are as low as 4%. In the United States, depression
prevalence has been reported around 9% in general popu-
lation [4,8,9] and varying between 5-13% among adultal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
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prevalence reported is 8.5%, of which women average
around 10% and men at 6.6% [11]. Globally prevalence of
depression has been reported as increasing, in the last dec-
ade [12]. In developing countries, 10-44% suffer from de-
pression and anxiety disorders, and less than 35% of the
depressed receive medical care [13]. Pakistan has an over-
all prevalence of 34% [14,15]. In Qatar, the prevalence is
27.8% [16].
In Saudi Arabia, prevalence has been estimated in sev-
eral studies, with rates varying in different populations,
age groups, times, and geographic locations. Psychiatric
morbidity in primary care was estimated in 1995 around
30-46% of the visiting patients [17]. In 2002, depression
and anxiety disorders were noted around 18% among
adults in central Saudi Arabia [18]. Al Ibrahim et al., in
2010 showed an overall prevalence of 41% in a systematic
review on depression [19]. El Rufaie et al., noted a 17%
prevalence of depression among residents of Dammam
[20]. Al Qahtani et al., in Asir reported a 27% prevalence
of depression in the year 2008 [21]. Abdul Wahid et al. in
2011, reported an overall prevalence of depression nearing
12%, with 6% as severe cases, in the south-eastern region
[22]. In Riyadh Becker et al., found depression prevalence
to be 20% in primary care settings [23,24].
WHO reported depression as the leading cause of dis-
ability as measured by years lost due to disability (YLD)
and the 4th leading contributor to the global burden of
disease, as calculated by (DALYs) Disability Adjusted Life
Years; depression is already the second major cause of
DALYs lost in the age category 15–44 years for both sexes
combined [5,7,15]. At present nearly half of lost productiv-
ity in the United States is attributable to depression, an esti-
mated $17 billion annual loss [9,25]. Saudi Arabia has a
high prevalence of depression, and as population grows,
along with rising risk factors of depression such as chronic
disease, stress of modernization, sedentary life style and so-
cial isolation, coupled with pre-existing stigmas of having a
mental health disorder, paucity of psychiatrist and resources
supporting mental health, the direct and indirect costs of
depression are expected to rise [26]. In Saudi Arabian
health care system in general and primary care settings in
particular, data regarding cost of treatment of depression
are rare to find. No Saudi studies regarding the cost of
treatment, lost productivity and/or monetary benefit of
screening for depression were found upon literature review.
Not just in Saudi Arabia, studies in other countries show
that primary care physicians fail to recognize depressive
symptoms in 30-50% of patients with depression [27]. In
the absence of specific protocol or screening tools, the phy-
sicians are less likely to explore somatic symptoms as hav-
ing possible links to depression [28]. On the other hand,
many patients think that doctors are for treating physical
symptoms only [29]. Almost two thirds of patients withdepression receive care in primary settings [30]. In a re-
cent study, Van den Berg et al. in 2011, calculated that
screening for depression is cost effective around 80%, even
for sub threshold depression, to prevent major depression
[31]. On the contrary, a Cochrane review found that rou-
tine depression screening had minimal effect on the man-
agement or outcomes of depression after six or 12 months
of follow-up [32].
United States Preventive Services Task Force (USPSTF)
has recommended screening elderly, adults and adolescents
12–18 years of age for depression [4,33,34]. Ultra-short
screening instrument, Patient Health Questionnaire (PHQ-
2) asking two simple questions about mood and anhedonia,
is as effective as longer screening instruments, such as the
Beck Depression Inventory (BDI) or Zung Depression Scale
(ZDS) [32,35,36]. PHQ-9 is one of the most common in-
struments used for depression screening, and it is increas-
ingly being used for confirmation of a positive PHQ-2
result. The PHQ-9 is valid, takes two to five minutes to
complete [4,37,38].
On the financial and cost aspect, Barrett et al., in 2005
found that there is no evidence that screening in primary
care populations is a cost effective strategy [39]. Valenstein
et al. and Nease et al., found that one time screening with
PHQ-9 is cost effective rather than the annual and peri-
odic screening [38,40]. Whooley et al. in 2009, found
screening to be cost effective in primary care setting, only
if followed by a collaborative care program [41].
The primary objective of this study was to estimate point
prevalence of screened depression in primary health care
settings in Riyadh, Saudi Arabia on the basis of screening
instruments. Secondary objectives include exploring asso-
ciation of screened depression with some risk factors,
comparing screening questionnaires PHQ-2 and PHQ-9,
conducting cost analysis for depression and estimating
possible cost-savings of screening for depression.
Methods
This cross-sectional study was conducted at King Abdul
Aziz Medical City-National Guard (KAMC-NG) in Riyadh,
Saudi Arabia, in three large primary care centers, serving a
population having nearly 60 thousand adults. Patients be-
tween 18–65 years, who attended primary care centers for
their regular visits and agreed to participate, were included
in this study. Patients who had preexisting depression or
were on anti-depressants and/or refused to participate in
this study, were excluded. Based on prevalence of depres-
sion at 20% from other studies [17,23,24] with ± 5% accur-
acy, confidence interval of 95%, power of .8, a sample size
of 482 was estimated using Piface software, 2004 version.
This study was approved by King Abdullah International
Medical Research Center, Riyadh. Data were collected using
PHQ-2 and PHQ-9 Arabic version validated questionnaires
for depression screening [42]. Other relevant demographic
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level of education, work status, monthly income, past med-
ical history, social habits and place of residence. The survey
forms were distributed and collected between 1st of June,
2012 till 31th of August, 2012. Each day, the nursing staff
distributed questionnaires to 2–5 patients in each center
based on a random number for the day, matching with the
last digit of medical record number. Verbal and written
consent were obtained from the respondents, clarifying the
main purpose of the study, the importance of the respond-
ent views, thanking in advance and assuring strict confiden-
tiality of the information. Patients without education were
assisted by an Arabic speaking nurse, who read out the
questionnaire to the patient, and documented responses.
During the process all data were kept secure. Completed
forms were forwarded to the data entry clerk, who entered
the data in IBM-SPSS version 20.
The PHQ-2 and PHQ-9 (Table 1) were analyzed in
terms of calculating the severity scores for each question,
for presence of depression symptoms over the last 2 weeks.
The score of severity of depression varied between 0 (not
present at all), 1 (present in several days), 2 (present more
than half the days) and 3 (present nearly every day). The
severity score of PHQ-2 was calculated and ranged be-
tween 0–6 points. Also, the severity score of PHQ-9
ranged between 0–27 points. The scores for PHQ-9 were
used to determine the presence of depression and its se-
verity depend on the following score ranges: 1–4 minimal
depression, 5–9 mild, 10–14 moderate, 15–19 moderate
to severe, and 20–27 severe [43]. For statistical analysis in
our study, a person with minimal score (1–4) on PHQ-9,
was not considered has ‘depressed’, and those with score ≥
10 (moderate - severe) were categorized needing medicalTable 1 Patient health questionnaire PHQ 2* & 9: screening in
For last 2 weeks how often have you been
bothered by any of the following problems?
Not at a
Little interest or pleasure in doing things* 0
Feeling down, depressed, or hopeless* 0
Trouble falling or staying asleep, or sleeping too much 0
Feeling tired or having little energy 0
Poor appetite or overeating 0
Feeling bad about yourself — or that you are
a failure or have let yourself or your family down
0
Trouble concentrating on things, such as reading the
newspaper or watching television
0
Moving or speaking so slowly that other people could
have noticed? Or the opposite — being so fidgety or restless
that you have been moving around a lot more than usual
0
Thoughts that you would be better off dead
or of hurting yourself in some way
0
If you checked off any problems, how difficult have these
problems made it for you to do your work, take care
of things at home, or get along with other people?
Not at all ditreatment for cost-analysis. For PHQ-2, presence or ab-
sence of depression was based on a score of 3 and above
out of 6 on the screening instrument [44]. Criteria for
diagnosis of Major Depressive Disorder based on DSM IV,
was not used as gold standard or validation of PHQ-9 cut-
off in this study, as the purpose of the study was to assess
the value of screening instrument for depression in pri-
mary care setting, and capturing as many adult patients
with depressive symptoms as reasonably possible.
The data was analyzed for all questions estimating fre-
quencies, percentages, means and standard deviations,
where applicable. The PHQ-9 scores were used along with
various demographic variables, for comparisons, using
statistical tests including Chi-square, Mann–Whitney
Test, and Kurskal-Wallis Test. Relationships between
PHQ 2, PHQ9 and “impact on daily life” question were ex-
plored, using linear regression.Cost analysis procedure
A simple cost-analysis was done by estimating direct and
indirect costs of depression, followed by an estimate of pos-
sible cost-savings that may emerge as a beneficial outcome
of improved screening and management of depression.
The following essential data were used from the current
study to insert in calculations for cost-analysis: Percentage
of males and females in the study, age range of patients,
who were primarily adults in their productive life 18–65
years, marital status, and percentage of housewives. Aver-
age monthly income of SAR 93,472/year, rounded to SAR
8000/month ($2133) in Saudi Arabia was also used, which
was quite close to monthly income average of study popu-
lation [45].strument for depression










fficult Somewhat difficult Very difficult Extremely difficult
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from the current study were included for cost-analysis.
For calculations, patients with mild symptoms were not
considered for treatment or cost-analysis, those with mod-
erate and severe symptoms of depression were grouped
together and rounded to 20% and considered eligible for
medication prescribed either by the family medicine phys-
ician or a psychiatrist. Psychotherapy was not added to the
costs, due to infrequent availability of the service in the re-
gion, and variability in practice which might have made
cost estimates fluctuate unreasonably. Literature review
shows that nearly 45% of patients with major depression
receive treatment, while most patients with major depres-
sion are managed by primary care physicians, only 5% get
referred to a psychiatrist and 1% get admitted for treat-
ment of depression [40]. These percentages were utilized
in cost-analysis.
Lifetime risk of suicide varies between 4-15% of patients
with major depression, and up to 3.6% of the depressed
patients with or without receiving treatment in primary
care for major depression are likely to commit suicide
every year [46]. For conservative estimates in calculations,
the suicide incidence rate was reduced to 1% of the pa-
tients with moderate-severe symptoms of depression
(0.2% of total), screened in this study. In order to estimate
indirect costs due to depression, the loss in productivity
was estimated based on available data, that on the average,
a depressed individual is absent from work no less than
18 days per year (rounded up to 20 workdays which is
equivalent to one month of work), a care-giver for the
depressed patient also takes 10 workdays off, and in
addition, the depressed individual may show up for
work, yet not work, an estimated loss of 11 days/year at-
tributed to Presenteeism [47,48].
Human capital approach was used to estimate indirect
costs. By this method a human being is valued by product-
ivity. In estimating costs, only per year costs were calcu-
lated and using 1000 patients as a reference, all percentages
were used to estimate number of patients affected within
that pool. Valenstein et al. have used a direct cost-offset of
20% and a similar indirect cost-differential between patients
treated for depression versus the untreated [40]. This differ-
ence was used to conduct sensitivity analysis, to come up
with conservative estimates and other possible scenarios.
Patient visits rate to physicians (general practitioners and
psychiatrists) for depression, were derived from the work of
Chisholm et al. [49]. Unit costs of physician fees and per
diem cost of hospital stay were averaged based on current
market charges in the private sector, and validated by local
experts in the field of psychiatry and health administration.
Blood money is a compensation given to the family of
the deceased, in case of accidental or homicidal death.
Diyya (Blood Money) estimate has been derived by aver-
aging homicidal and accidental death cost of 2011 revisedrates [50]. This is based on the assumption that suicidal
death although intentional yet can sometimes be acciden-
tal. For the sake of conservative estimate, Diyya was taken
into account instead of the ‘life-time’ monetary loss of an
earning person who commits suicide that can be extended
to the whole span of productive life, with annual earnings
discounted at 3-5%. With an average monthly salary of
SAR 8000 ($2133), the loss would be in millions per per-
son depending upon the age of suicidal death. The absen-
tee rate was applied to a third of depressed patients
assuming that only 1/3 of the population was employed.
Similarly home-makers were estimated to be only half of
the females in the study. Care-givers productivity losses
were applied to both the employees. The home-makers’
earning were estimated based on the average monthly sal-
aries of the persons doing various jobs in the house, i.e.
housekeeping, cooking and babysitting. Other jobs were
excluded from the analysis. A low total cumulative esti-
mate of SAR 4000 ($1067) was used as monthly income,
for all the job-types carried out at home.
Results
A total of 550 questionnaires were distributed, 39 (7%)
refused to participate, 23 (4.1%) were excluded from the
study with pre-existing depression or affective disorders
according to the medical records, and 11 (2%) incom-
plete questionnaires were rejected. The analysis included
477 patients; males were 161 (33.8%) and females were
316 (66.2%), 77.4% were married, with mean age of
38 years (±12 SD), and 50.9% were between 30–44 years.
Study subjects living single were 108 (22.6%). Nearly
60% of patients had high school education, illiterate were
94 (19.7%), and those with degree above high school
were 96 (20.1%). Those currently having an occupation
were 259 (54.3%), housewives 45% and over 85% were
living in a rented house. Reporting as smokers were 23
(4.8%), and coffee drinkers were 75.3%. The study found
the point-prevalence of screened depression to be 49.9%
among the adult visitors to primary healthcare, based on
the predetermined cut-off limits on screening instru-
ments. Of the screened depressed, mild were 31%, mod-
erately depressed were 13.4%, moderate to severe 4.4%
and severe were 1% (Table 2).
The number and percentage of patients responding to
questions with various durations/severity of depression are
given in Table 3. There was a significant relationship be-
tween prevalence of depression with female gender (Mann
Whitney 22864, Z 1.97, p-value 0.049), and with higher
level of education (Kruskal Wallis chi-square 14.9, p-value
0.002). No other significant relationships were found with
other variables such as marital status, age, monthly in-
come, working status, house space, house owner ship,
chronic diseases, coffee intake and smoking among the
study subjects.
Table 2 Prevalence of depression among study subjects
PHQ-9
5 category scale Minimal Mild Moderate Moderately severe Severe Total
No. of patients 239 148 64 21 5 477
% of patients 50.1 31.0 13.4 4.4 1.0 100
2 category scale Absent Present
No. of patients 239 238 477
% of patients 50.1 49.9 100
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the severity scores for each question for the last 2 weeks.
The severity score of PHQ-2 ranged between 0–6 points
(mean of 1.57 ± 1.63SD) and that of PHQ-9 was found
ranging between 0–27 points (mean of 5.57 ± 4.91SD) (See
Figure 1). Cronbach’s alpha between PHQ-2 and PHQ-9
was 0.641 and on standardized items (2) was 0.882
(Figure 1).
PHQ 9 and PHQ 2 scores were also positively correlated
to ‘impact on daily living’ with R = 0.49, R2 = 0.24, F Statis-
tic = 150.3, p-value <0.001, and R = 0.42, R2 = 0.18, F Stat-
istic = 102.2, p-value <0.001 respectively, with regression
equations PHQ-9 = 3.6 + 4.2 (Q-10), and PHQ-2 = 1 + 1.2
(Q-10).
The cost analysis results are shown in Table 4.
Discussion
Nearly half of the adults walking into primary care
clinics had depressive symptoms, in our study. This find-
ing is similar to that reported by Al Ibrahim et al., in
their systematic review in 2010 [19]. Moderate or severe
depression in our study totaled around 19%, which is a
little higher than 12% reported by Abdul Wahid et al., in
2011 in primary care settings, but closer to reported by
Becker et al., at 20% in 2002 [22,24] and by El Rufaie
et al., 25 years ago at 17% [20]. Abdul Wahid et al.,Table 3 PHQ-2* & PHQ-9 Prevalence of screened depression i
No Item Number of patients
Not at all S
1 Loss of interest* 226 (47.4)
2 Feeling depressed* 257 (53.9)
3 Trouble sleeping. 242 (50.7)
4 Feeling tired. 150 (31.4)
5 Poor appetite or eating. 262 (54.9)
6 Loss of self-esteem. 376 (78.8)
7 Low level of concentration. 296 (62.1)
8 Low voice or edgy. 346 (72.5)
9 Suicidal ideation. 459 (96.2)
10 Feeling difficulty in general. 265 (55.6)conducted their study in Sharurah, Southeastren region
of Saudi Arabia, which is generally considered a rural
area compared to the capital city, Riyadh. Several studies
have shown that prevalence expected to be less in rural
area comparing to urban area [11,15]. Another reason of
this variation could be due to use of different scales for of
screening depression in the studies, e.g. using Hospital
Anxiety and Depression Scale (HAD), versus the PHQ
scale [20]. Compared to general population, it can be as-
sumed that primary care visitors are more likely to have
depression, because of their health status. Al-Shammari
et al., in 1999 studied depression in elderly and reported
39% prevalence with 8.4% of severe cases [51]. Comparing
our study results with a study done in United States, we
found our rates to be higher across the board; mild cases
(31% vs 9.9%), moderate (13.4% vs 3.7%), moderate to se-
vere cases (4.4% vs 1.4%), and severe (1% vs 0.5%) [52].
A significant relationship between depression and female
gender was found. Similar relation was reported in many
studies either local [18,20,22,23] or international [4,11,52].
In our study we also found significant relationship of de-
pressive symptoms with higher level of education. No local
study has noted this relationship previously or one found
no differences between being literate or illiterate [21]. Many
international studies however differ in results and found
the opposite that depression was more likely to ben study subjects (477)
in each category (%)
everal days More than half days Nearly every day
141 (29.6) 47 (9.9) 63 (13.2)
146 (30.6) 42 (8.8) 32 (6.7)
128 (26.8) 62 (13.0) 45 (9.4)
199 (41.7) 68 (14.3) 60 (12.6)
116 (24.3) 50 (10.5) 49 (10.3)
77 (16.1) 12 (2.5) 12 (2.5)
125 (26.2) 27 (5.7) 29 (6.1)
80 (16.8) 21 (4.4) 30 (6.3)
11(2.3) 4 (0.8) 3 (0.6)
199 (41.7) 10 (2.1) 3 (0.6)
Figure 1 Correlation between PHQ-2 & PHQ-9 scores. R = 0.79, R2 = 0.62, F Statistic = 780.5, p-value <0.001. Regression equation: PHQ-9 = 1.83 +
2.37 x PHQ-2.
Table 4 Cost of depression based on screening instrument PHQ-9 cut-off score ≥ 10
Direct cost Rating basis Unit cost (SAR) Patients/1000* Total (SAR) Comment
PHC screening Once/year 10 1,000 10,000 Use of PHQ-9 by nurse
GP visits 4 visits/year 100 90 36,000 45% needing treatment (90/200)
Specialist visits 8 visits/year 300 10 24,000 5% referred to psychiatrist (10/200)
Medication Full year 200/month 90 216,000 45% on meds (90/200)
Hospitalization 11 days/year 1,500/day 2 33,000 1% hospitalized (2/200)
Total 319,000 $85,067*
Indirect cost Rating basis Unit cost (SAR) Patients/1000 Total (SAR) Comment
Suicide Diyya 2011 350,000/life 2 700,000 Human life valued by ‘Blood Money’ rate
Absenteeism 20 days/year 8,000/month 30 240,000 20 work days equivalent to 1 month for 30/90 patients
Presenteeism 11 days/year 8,000/month 30 120,000 Average monthly salary in SA for 1/3 (30/90 patients)
Homemaker 20 days/year 4,000/month 30 120,000 Housemaid + babysitter + cook = Salary (30/90)
Care-giver 10 days/year 4,000/month 60 120,000 Conservative loss of care giver days
Total 1,300,000 $346,667
Grand total 1,619,000 $431,733
Sensitivity analysis
Cost differential 20% Untreated-Treated 323,800 $86,347
Saving/person 324 For 1,000 adults screened in PHC = $86
Decreasing indirect cost & direct cost by 50% 490,500 650,000- 159,000 = ½ million SAR
Saving/person 500 For 1,000 adults screened in PHC = $133
*20% patients with score ≥ 10, categorized as ‘depressed’ in the study (200/1000). **$1 = 3.75SAR.
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could be due to high unemployment rate in Saudi Arabia,
being a stressor for the educated. No other significant rela-
tionships were found with other variables, although, other
studies have found depression to be associated with being
in a younger age group [4,16,18,21], marital status specific-
ally being divorced and widow [4,16,57], low monthly in-
come [4], working status being employed [22] or losing the
work [4], living in small house space [22], house owner ship
and/or having chronic diseases [18]. In addition, no associ-
ation was found with social habits such as coffee intake or
smoking among study subjects.
The poor screening and diagnostic practices of de-
pressed patients by primary care physicians [24,25] en-
couraged us to search a simple, reliable, efficient and
easy to interpret tool. We chose the PHQ over many
other modalities such as Beck Depression Inventory
BDI, Rahim-Anxiety-Depression Scale RADS, and Gen-
eral Health Questionnaire GHQ for two reasons; Arabic
version was validated by a study done on our population
[24], and it had high sensitivity and specificity [4,38]. To
further satisfy our needs to simplify, we explored the use
of PHQ-2 by correlating with PHQ-9. Seeking psychi-
atric help is still considered as a stigma in the regional
society. Psychiatrists are few and far between in Saudi
Arabia. Professionals such as psychologists and behavior
therapists are even less. Data are lacking on depression
and on other psychiatric ailments. Individuals and the
society as a whole are stressed in trying to adapt to pace
of modernization. In retrospect not more than half a
century ago, lifestyle of the majority of the population
was nomadic and there was hardly any wealth. Mental
health services are still not recognized as a pressing need
of the time in Saudi society. Even though most of the
health care structure is dependent on the government,
the delivery of organized psychiatric services is moving
at a faster pace in the private sector.
There is dearth of data regarding the cost of depression
screening in Saudi population. Our simplified analysis
showed that the total direct cost of care for a thousand
persons screened for depression in primary healthcare set-
ting was one third million SAR/year ($85,067) (Table 4).
The indirect costs due to lost productivity came around
1.3 million SAR per year ($346,667) for a thousand per-
sons screened in primary health care. This is a conserva-
tive estimate. A total loss due to depression was around
1.62 million SAR per 1000 persons screened ($431,733).
Based on the assumptions of another study [40], apply-
ing the cost differential of 20% savings in treated versus
untreated patients with depression, revealed net cost sav-
ing of over a third of a million SAR, ($86,347) i.e. For
every person who is walking in the PHC clinics, over 300
SAR ($80) can be saved per person per year, if screened
and subsequently treated if required. Similarly, if it isassumed that treatment costs would go up by say 50%, as
more patients are likely to received medical treatment for
depression as screening becomes common practice, it is
also assumed simultaneously that it would reduce indirect
losses in productivity by a certain percentage, say 50%, as
treated patients are less likely to be absent from work and
coupled with reduced risk of suicide, it is estimated that
over half a million SAR ($130,800) can be saved per thou-
sand persons screened in the primary care clinics. This
saving is up to SAR 500 per person ($133) screened in the
clinic.
Limitations
Our study has several limitations such as volunteer bias of
including only those agreeing to participate, conducting
study in summer so seasonal depression could not be in-
cluded, based on primary care settings with more female
and sick visitors thereby lacking generalizability, and cost
estimates had no long term component and were based
on several assumptions. In addition we did not use gold
standard diagnostic criteria such as DSM IV for major de-
pressive disorder rather relied on cutoff of PHQ-9 scores
of ≥ 5 for point prevalence estimates for screened depres-
sion and score of ≥ 10 for cost-analysis estimates of those
who may require treatment. This might have resulted in
over-estimates of point prevalence of screened vs actual
depression in primary care setting, but considering that
nearly 30-50% of actual depression is missed, and of the
depressed only 45% get treatment, our cost estimates may
not be unreasonable. Our cost estimates are limited by
several assumptions due to lack of resources on data re-
lated to healthcare costs, in the country.
Conclusion & recommendation
Nearly half of the patients visiting primary care have some
depressive symptoms, which require further exploration
into their psychiatric history. The female gender and
higher education level were factors associated with depres-
sion. Majority of the cases were mild to moderate cases.
As screening tools, PHQ-2 and PHQ-9 correlate well and
can easily be adopted in primary care. Simple cost esti-
mates using basic percentages, using references from other
studies and making some safe assumptions, it can be dem-
onstrated that of screening for depression in primary care,
is cost-saving.
Our results need further validation by conducting
population based studies, or within primary care clinics
with a larger sample size and confirmation of screened
patients with some gold standard for measuring depres-
sion. It is also recommended to increase the awareness
of benefits of early diagnosis of patients to prevent major
form of depression and cost saving of health system.
Programs for screening depression should be imple-
mented in primary care settings.
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